Related Experiment Video

Updated: Sep 19, 2025

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
11:33

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes

Published on: March 12, 2013

13.5K

KCNIP2: A key regulator in cardiac electrophysiology and tumorigenesis

Yihao Wang1, Rui Wang1, Weisong Zhang1

  • 1Department of Thoracic Surgery, Affiliated Hospital 6 of Nantong University, Yancheng Third People's Hospital, Yancheng 224000, PR China; Medical School of Nantong University, Nantong 226007, PR China.

Gene
|June 9, 2025
PubMed

Insights

Kv Channel Interacting Protein 2 (KCNIP2) regulates potassium channels and impacts heart function and tumor growth. This review explores KCNIP2

Area of Science:

  • Cardiovascular Biology
  • Molecular Oncology
  • Biophysics

Background:

  • KCNIP2 (Kv Channel Interacting Protein 2) is a key regulator of potassium channel function.
  • Emerging evidence links KCNIP2 expression to tumorigenesis, extending its known roles in cardiac electrophysiology.

Purpose of the Study:

  • To review the structure, function, and cardiac roles of KCNIP2.
  • To synthesize recent findings on KCNIP2's involvement in cardiac diseases.
  • To explore KCNIP2's emerging role in cancer development and molecular mechanisms.

Main Methods:

  • Literature review of existing studies on KCNIP2.
  • Analysis of research on KCNIP2 in cardiac electrophysiology and disease models.
  • Examination of studies investigating KCNIP2 in various tumor types.

Main Results:

  • KCNIP2 significantly influences cardiac electrical activity and is implicated in myocardial hypertrophy, heart failure, and arrhythmias.
  • Altered KCNIP2 expression is associated with the development and progression of tumors.

Conclusions:

  • KCNIP2 is a critical protein with dual roles in cardiac health and disease, and in cancer biology.
  • Further research into KCNIP2's molecular mechanisms is warranted for therapeutic targeting in both cardiovascular conditions and oncology.
Keywords:
Cardiovascular DiseasesI(to)KCNIP2KvPathwayTumor

More Related Videos

Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection08:52

Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection

Published on: February 17, 2015

9.8K
Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk05:15

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk

Published on: July 27, 2022

1.7K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.2K
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K